Table 1.
Surface marker expression of hAECs, as determined by flow cytometry
| Surface marker | Donor 1 | Donor 2 | Donor 3 |
|---|---|---|---|
| Immunological markers | |||
| HLA-ABC | ++ | ++ | ++ |
| HLA-DR | − | − | − |
| CD80 | − | − | − |
| CD86 | − | − | − |
| HLA-G | ++ | ++ | + |
| Phenotypic markers | |||
| EpCAM | ++ | ++ | ++ |
| CD90 | + | + | + |
| CD73 | − | − | − |
| CD105 | − | − | − |
| CD45 | − | − | − |
| CD34 | − | − | − |
| Integrins | |||
| Integrin-α2/CD49b | ++ | + | ++ |
| Integrin-α4/CD49d | − | − | − |
| Integrin-α6/CD49f | ++ | + | + |
| Integrin-β1/CD29 | ++ | ++ | ++ |
| Ig superfamily CAMs | |||
| ICAM-1/ CD54 | − | − | − |
| VCAM-1/ CD106 | − | − | − |
| Other | |||
| CXCR4/ CD184 | − | − | − |
| CD44 | − | − | − |
−, Not detected; +, low-intermediate expression (5–50 %); ++, high expression (>50 %)